Aug 6, 2026 11:34AM
Aug 6, 2026 11:29AM
Jul 22, 2026 08:30AM
Jul 6, 2026 08:45AM
Jun 29, 2026 09:30AM
Jun 29, 2026 09:30AM
Jun 25, 2026 09:20AM NeuroSense reports biomarker findings from small Alzheimer's PrimeC trial
Jun 25, 2026 09:20AM
Jun 22, 2026 09:00AM
Jun 11, 2026 09:02AM
Jun 11, 2026 09:00AM
Jun 9, 2026 09:01AM
Jun 9, 2026 09:00AM
Apr 6, 2026 09:20AM NeuroSense receives Brazilian patent for PrimeC drug composition
Apr 6, 2026 09:20AM
Mar 31, 2026 09:20AM
Mar 24, 2026 09:03AM
Mar 24, 2026 09:00AM
Mar 18, 2026 08:00AM
Mar 16, 2026 11:34AM
Mar 16, 2026 11:33AM JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity
Mar 9, 2026 11:07AM
Feb 18, 2026 09:05AM
Feb 18, 2026 09:05AM
Feb 9, 2026 09:20AM
Feb 9, 2026 09:20AM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
Jan 8, 2026 08:45AM
Dec 22, 2025 09:18AM
Dec 22, 2025 09:17AM
Dec 4, 2025 07:30AM
Nov 24, 2025 09:56AM
Nov 24, 2025 09:56AM
Oct 6, 2025 09:00AM NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers
Sep 10, 2025 02:30PM
Sep 4, 2025 08:49AM
Sep 4, 2025 08:49AM
Aug 1, 2025 09:00AM
Jul 22, 2025 08:42AM
Apr 24, 2025 09:09AM
Apr 24, 2025 09:09AM NeuroSense Therapeutics Releases Letter to Shareholders Outlining Clinical Progress, Regulatory Strategy, and Partnership Update
Apr 9, 2025 08:30AM
Apr 9, 2025 08:30AM
Apr 7, 2025 05:14PM
Apr 4, 2025 09:10AM
Mar 20, 2025 10:30AM
Mar 17, 2025 08:30AM
Jan 6, 2025 09:02AM Neurosense Therapeutics (NRSN) Regains Nasdaq Compliance
Jan 6, 2025 09:00AM

328,151 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All